Ainhoa Hernández

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

Solange Peters, Jean-Louis Pujol, Urania Dafni et al. · Annals of Oncology · 2021 · 105 citations · Full text

Oncology, Immune Checkpoint Inhibitor, Consolidation Nivolumab +6

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

Benjamin Besse, Enriqueta Felip, Rosario García Campelo et al. · Annals of Oncology · 2023 · 57 citations · Full text

Correlation between PD-L1 expression and <i>MET</i> gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver

Marta Doménech, Ana M Muñoz‐Mármol, José Luís Mate et al. · Oncotarget · 2021 · 16 citations · Full text

SEOM clinical guidelines for anaplastic gliomas (2017)

Carmen Balañá, M. Alonso, Ainhoa Hernández et al. · Clinical & Translational Oncology · 2017 · 15 citations · Full text

Surgical Oncology, Cancer Management, Pathology +21

Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy

Cristina Carrato, Francesc Alameda, Anna Esteve‐Codina et al. · Clinical Cancer Research · 2020 · 12 citations · Full text